GHRH analog with Drug Affinity Complex (DAC) technology for extended half-life. Enables sustained GH secretion research with prolonged receptor occupancy (~6-8 days).
CJC-1295 with DAC (Drug Affinity Complex) is a synthetic 30-amino acid GHRH analog incorporating a maleimidoproprionic acid-lysine modification that enables covalent binding to serum albumin. This DAC technology dramatically extends the plasma half-life to approximately 6-8 days in animal models, enabling sustained GHRH receptor occupancy. It serves as a key research tool for studying pulsatile versus sustained GH secretion dynamics.
SPPS synthesis with DAC conjugation; HPLC >=99%; LC-MS confirmed; endotoxin <=1 EU/mg. Full CoA provided.
For Research Use Only. Not for human or veterinary use.
| Product Name | CJC1295 DAC |
| CAS Number | 863288-34-0 |
| Purity | ≥99% (by HPLC) |
| Molecular Weight | 3,367.97 g/mol |
| Molecular Formula | C152H252N44O42S |
| Appearance | White to off-white lyophilized powder |
| Storage | Store at -20C desiccated. Stable >=24 months. Reconstituted: use within 14 days at 2-8C. |
| Available Sizes | 5mg · Custom |
Store at -20C desiccated. Stable >=24 months. Reconstituted: use within 14 days at 2-8C.
24 months from manufacture when stored properly.
Cold-chain shipping with ice packs. Express delivery to 35+ countries.
Get premium research-grade peptides with complete documentation and worldwide delivery.
CJC1295 DAC · CAS 863288-34-0
Quote request sent! We'll respond within 24 hours.
